MD Magazine |
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
FDA.gov The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy ... FDA Approves Marketing for First AI Device for Diabetic Retinopathy Detection |
April 11, 2018 at 12:21PM | marketing - Google News
FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems - FDA.gov
marketing - Google News
Nenhum comentário:
Postar um comentário